Trade Summary

3 days ago, Roberts Brandi, serving as Chief Financial Officer at Definium Therapeutics, Inc. (DFTX), sold 3,013 shares at $45.03 per share, for a total transaction value of $135,675.39. Following this transaction, Roberts Brandi now holds 209,487 shares of DFTX.

This sale represents a 1.42% decrease in Roberts Brandi's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 4:30 PM ET, 1 day after the trade was made.

Definium Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.